Robert A Wood Selected Research

Peanut Hypersensitivity (Peanut Allergy)

1/2022	Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study.
1/2021	Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy Research.
11/2020	Early epitope-specific IgE antibodies are predictive of childhood peanut allergy.
1/2020	Peanut allergy diagnosis: Moving from basic to more elegant testing.
1/2019	Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety.
1/2019	The Consortium for Food Allergy Research (CoFAR): The first generation.
11/2018	AR101 Oral Immunotherapy for Peanut Allergy.
4/2017	Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults.
5/2015	Suppression of the immunologic response to peanut during immunotherapy is often transient.
5/2015	A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert A Wood Research Topics

Disease

41	Asthma (Bronchial Asthma) 01/2022 - 05/2002
40	Hypersensitivity (Allergy) 01/2022 - 04/2003
38	Food Hypersensitivity (Food Allergy) 01/2022 - 04/2003
24	Peanut Hypersensitivity (Peanut Allergy) 01/2022 - 07/2003
8	Egg Hypersensitivity (Egg Allergy) 01/2022 - 12/2007
8	Anaphylaxis (Anaphylactic Shock) 10/2021 - 07/2003
8	Milk Hypersensitivity (Milk Allergy) 01/2019 - 06/2003
6	Respiratory Sounds (Crackle) 11/2021 - 05/2009
6	Rhinitis 10/2019 - 11/2004
4	Enterocolitis 01/2021 - 04/2003
3	Allergic Rhinitis 12/2021 - 11/2004
3	Inflammation (Inflammations) 11/2021 - 01/2016
3	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 10/2021 - 07/2013
3	Wheat Hypersensitivity (Wheat Allergy) 01/2021 - 05/2009
3	Tetanus 12/2018 - 09/2008
3	Eczema 01/2015 - 04/2011
2	Vomiting 01/2021 - 01/2019
2	Shock 01/2021 - 04/2017
2	Angioedema 01/2019 - 02/2014
2	Atopic Dermatitis (Atopic Eczema) 01/2015 - 02/2014
2	Birth Weight (Birth Weights) 07/2010 - 11/2009
1	Airway Obstruction (Choking) 12/2021
1	Venom Hypersensitivity 12/2021
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2021
1	Biliary Atresia 10/2021
1	COVID-19 01/2021
1	Dehydration (Water Stress) 01/2021
1	Hypotension (Low Blood Pressure) 01/2021
1	Immune System Diseases (Immune Disorders) 01/2020
1	Eosinophilic Esophagitis 01/2019

Drug/Important Bio-Agent (IBA)

46	Immunoglobulin E (IgE)IBA 11/2021 - 07/2003
36	AllergensIBA 01/2022 - 05/2002
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2003
8	CytokinesIBA 09/2017 - 11/2009
7	Omalizumab (Xolair)FDA Link 12/2021 - 02/2011
6	AntigensIBA 01/2021 - 01/2015
6	Epinephrine (Adrenaline)FDA LinkGeneric 01/2019 - 05/2007
5	VaccinesIBA 01/2021 - 09/2008
3	EndotoxinsIBA 01/2022 - 04/2011
3	Methacholine Chloride (Methacholine)FDA Link 11/2021 - 12/2005
3	Interleukin-13IBA 11/2021 - 01/2021
3	Interleukin-4 (Interleukin 4)IBA 01/2021 - 05/2010
3	EpitopesIBA 01/2021 - 07/2003
3	AntibodiesIBA 01/2021 - 11/2020
3	Interleukin-8 (Interleukin 8)IBA 01/2021 - 11/2009
2	RNA (Ribonucleic Acid)IBA 12/2021 - 12/2018
2	Interleukin-5 (Interleukin 5)IBA 01/2021 - 01/2016
2	anti-IgE antibodiesIBA 01/2021 - 03/2012
2	Interleukin-10 (Interleukin 10)IBA 01/2021 - 05/2010
2	Messenger RNA (mRNA)IBA 01/2021 - 05/2010
2	Interleukin-9 (Interleukin 9)IBA 01/2021 - 01/2016
2	Immunoglobulin G (IgG)IBA 10/2019 - 02/2014
2	Biomarkers (Surrogate Marker)IBA 06/2019 - 05/2010
2	CotinineIBA 01/2018 - 04/2011
2	SmokeIBA 01/2018 - 10/2016
2	Antiviral Agents (Antivirals)IBA 01/2017 - 05/2009
2	Caseins (Casein)FDA Link 05/2010 - 09/2005
2	montelukast (Singulair)FDA Link 11/2004 - 05/2002
1	MucinsIBA 12/2021
1	AdipokinesIBA 11/2021
1	LeptinIBA 11/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 10/2021
1	AlarminsIBA 01/2021
1	nemolizumabIBA 01/2021
1	tezepelumabIBA 01/2021
1	Lipid NanoparticlesIBA 01/2021
1	allergen Bla g 1IBA 01/2021
1	mepolizumabIBA 01/2021
1	reslizumabIBA 01/2021
1	benralizumabIBA 01/2021
1	tralokinumabIBA 01/2021
1	dupilumabIBA 01/2021
1	ligelizumabIBA 01/2021
1	Interleukin-33IBA 01/2021
1	mRNA VaccinesIBA 01/2021
1	Biological ProductsIBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Nucleic AcidsIBA 01/2021
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2021
1	PolymersIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	IntegrinsIBA 01/2021
1	Interleukin-12 (IL 12)IBA 01/2021
1	VenomsIBA 02/2020
1	Pharmaceutical PreparationsIBA 02/2020
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2020
1	5-methyltetrahydrofolateIBA 01/2020
1	SphingolipidsIBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	insulin receptor-related receptor (IRR)IBA 01/2019
1	Milk Proteins (Milk Protein)IBA 01/2019
1	DNA VaccinesIBA 01/2019
1	16S Ribosomal RNAIBA 01/2018

Therapy/Procedure

33	Immunotherapy 01/2022 - 01/2005
9	Therapeutics 01/2022 - 02/2012
2	Injections 02/2016 - 02/2014
1	Liver Transplantation 10/2021
1	Transplantation 10/2021
1	Diet Therapy (Therapy, Diet) 01/2021
1	Biological Therapy 01/2019